Browse the full directors' dealings record of 九洲药业, a listed equity based in France. Shares are quoted on FR FR, under the supervision of AMF. Market capitalisation: €15.9bn. The latest transaction was disclosed on 8 July 2024 — Purchase. Among the most active insiders: 沙裕杰. The full history is openly available.